AstraZeneca vaccine arrives in New Zealand

The first arrival of AstraZeneca vaccines arriving in New Zealand today. Supplied image.

New Zealanders will soon be able to access a second type of Covid-19 vaccine, Minister for Covid-19 Response Chris Hipkins has confirmed.

A shipment of 100,000 doses of the AstraZeneca Covid-19 vaccine arrived in New Zealand today from Australia.

“Enough for 50,000 people, these doses are for people who can’t have the Pfizer Covid-19 vaccine for medical reasons, and for those who would like an option other than the Pfizer vaccine,” says Hipkins.

From November 26, anyone aged 18 and older who wishes to have the AstraZeneca vaccine will be able to book an appointment on BookMyVaccine.nz or by calling Healthline.

“DHBs are preparing to offer the AstraZeneca vaccine, including arranging for specific clinics to administer the vaccine, and making sure the workforce is trained to deliver it,” Hipkins explains.

“AstraZeneca will be available at a limited number of sites across the country as Pfizer is the main Covid-19 vaccine we are using in New Zealand.

“Officials have also been working closely with colleagues in Australia and with AstraZeneca to secure delivery of these doses from the manufacturer in Melbourne.

“We want to thank the Australian Government for their cooperation in providing timely access to these doses and AstraZeneca for their support of this arrangement.”

Medsafe granted provisional approval of the AstraZeneca vaccine for people aged 18 and older in July this year.

The AstraZeneca Covid-19 vaccine is a two-dose, viral vector vaccine, with a four to 12 week gap between doses.

“New Zealand has an advance purchase agreement with AstraZeneca for 7.6 million doses of the Covid-19 vaccine,” says Hipkins.

“The 100,000 doses which have arrived from Australia are part of this original purchase agreement. The Covid-19 Technical Advisory Group provided advice to Cabinet this week on the use of the vaccine in New Zealand. Cabinet has since granted a ‘decision to use’.

Hipkins says the Pfizer vaccine remains the preferred Covid-19 vaccine for use in New Zealand and that supply is not an issue.

“Looking at today’s case numbers, and the current geographical spread, I can’t stress enough how important it is that we have as many people as possible vaccinated,” says Hipkins.

“Vaccination is the best way to protect ourselves, our whānau and our communities against Covid-19.”




You may also like....

0 Comments

There are no comments on this article.

Leave a Comment

You must be logged in to make a comment. Login Now